Gou Zixuan, Li Jiannan, Liu Jianming, Yang Na
Bethune First Clinical School of Medicine, The First Hospital of Jilin University, Changchun, China.
Department of General Surgery, The Second Hospital of Jilin University, Changchun, China.
Front Cell Dev Biol. 2024 Apr 17;12:1378302. doi: 10.3389/fcell.2024.1378302. eCollection 2024.
Cancer-associated fibroblasts (CAFs), a class of stromal cells in the tumor microenvironment (TME), play a key role in controlling cancer cell invasion and metastasis, immune evasion, angiogenesis, and resistance to chemotherapy. CAFs mediate their activities by secreting soluble chemicals, releasing exosomes, and altering the extracellular matrix (ECM). Exosomes contain various biomolecules, such as nucleic acids, lipids, and proteins. microRNA (miRNA), a 22-26 nucleotide non-coding RNA, can regulate the cellular transcription processes. Studies have shown that miRNA-loaded exosomes secreted by CAFs engage in various regulatory communication networks with other TME constituents. This study focused on the roles of CAF-derived exosomal miRNAs in generating cancer malignant characteristics, including immune modulation, tumor growth, migration and invasion, epithelial-mesenchymal transition (EMT), and treatment resistance. This study thoroughly examines miRNA's dual regulatory roles in promoting and suppressing cancer. Thus, changes in the CAF-derived exosomal miRNAs can be used as biomarkers for the diagnosis and prognosis of patients, and their specificity can be used to develop newer therapies. This review also discusses the pressing problems that require immediate attention, aiming to inspire researchers to explore more novel avenues in this field.
癌症相关成纤维细胞(CAFs)是肿瘤微环境(TME)中的一类基质细胞,在控制癌细胞侵袭和转移、免疫逃逸、血管生成以及化疗耐药性方面发挥着关键作用。CAFs通过分泌可溶性化学物质、释放外泌体以及改变细胞外基质(ECM)来介导其活性。外泌体包含各种生物分子,如核酸、脂质和蛋白质。微小RNA(miRNA)是一种22 - 26个核苷酸的非编码RNA,可调节细胞转录过程。研究表明,CAFs分泌的载有miRNA的外泌体与其他TME成分参与各种调节通讯网络。本研究聚焦于CAF衍生的外泌体miRNA在产生癌症恶性特征中的作用,包括免疫调节、肿瘤生长、迁移和侵袭、上皮 - 间质转化(EMT)以及治疗耐药性。本研究全面考察了miRNA在促进和抑制癌症中的双重调节作用。因此,CAF衍生的外泌体miRNA的变化可作为患者诊断和预后的生物标志物,其特异性可用于开发更新的疗法。本综述还讨论了需要立即关注的紧迫问题,旨在激励研究人员在该领域探索更多新途径。